16alpha-Hydroxyprednisolone

CAS No. 13951-70-7

16alpha-Hydroxyprednisolone ( —— )

Catalog No. M21638 CAS No. 13951-70-7

16alpha-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 35 Get Quote
200MG 50 Get Quote
500MG 82 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    16alpha-Hydroxyprednisolone
  • Note
    Research use only not for human use.
  • Brief Description
    16alpha-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide.
  • Description
    16alpha-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13951-70-7
  • Formula Weight
    376.44
  • Molecular Formula
    C21H28O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
  • Chemical Name
    (8S9S10R11S13S14S16R17S)-111617-Trihydroxy-17-(2-hydroxyacetyl)-1013-dimethyl-7891112141516-octahydro-6H-cyclopenta[a]phenanthren-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J?nsson G Astr?m A Andersson P. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver[J]. drug metabolism & disposition the biological fate of chemicals 1995 23(1):137.
molnova catalog
related products
  • 7-Hydroxyaristolochi...

    7-Hydroxyaristolochic acid A is a natural product from Aristolochia debilis Sieb.

  • Tris(2,2,2-trifluoro...

    Tris(2,2,2-trifluoroethyl) borate is mostly used in condensation reactions.

  • Pomalidomide-PEG2-OH

    Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.